hCG, AFP, and uE3 patterns in the 14–20th weeks of Down's syndrome pregnancies
- 1 July 1992
- journal article
- Published by Wiley in Prenatal Diagnosis
- Vol. 12 (7) , 619-624
- https://doi.org/10.1002/pd.1970120709
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- A single chorionic gonadotropin assay for maternal serum screening for Down's syndromePrenatal Diagnosis, 1990
- Maternal serum markers in screening for Down syndromeClinical Genetics, 1990
- Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levelsAmerican Journal of Obstetrics and Gynecology, 1989
- Human chorionic gonadotropin levels in pregnancies with aneuploid fetusesPrenatal Diagnosis, 1989
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984